Major Covid Vaccine Stocks Soar Amid Rising Concerns Over New Variants
As new Covid variants emerge, major vaccine stocks are witnessing a notable boost, signaling hope for both companies and investors alike. Novavax and Moderna, in particular, have made significant strides in response to these new strains. This article provides insights into the impact of new Covid strains on vaccine stocks and highlights the performance of Novavax and Moderna stocks amidst the changing landscape of the pandemic.